August 13, 2007—FlowMedica Inc, Fremont, Calif, a medical device company focused on targeted renal therapy, recently appointed Gary Saxton president and CEO.
“Gary brings both extensive strategy development as well as operating experience to FlowMedica, and joins the company as we expand our clinical programs and commercial activities," said Phil Hopper, chairman of FlowMedica’s board. "His experience within the interventional and surgical specialties will help us optimize the many opportunities we have to prevent and treat acute renal injury and renal failure. We also look forward to leveraging his business development background to forge alliances with a variety of industry partners.”
Saxton most recently served as executive vice president and COO of BioSphere Medical Inc, Rockland, Mass, a medical device company that developed and commercialized minimally invasive therapeutic applications for microsphere technology.  

—Cat Vasko